Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
MATILDE Chemotherapy Regimen for Primary CNS Lymphoma
Neurol 82:1370-1373, Ferreri, A.J.M.,et al, 2014
Salvage Whole Brain Radiotherapy for Recurrent or Refractory Primary CNS Lymphoma
Neurol 69:1178-1182, Hottinger,A.F.,et al, 2007
Clinicopath Conf., Primary Diffuse Large-B-Cell Lymphoma of the Brain
NEJM 352:185-194, Case 1-2005, 2005
NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005
Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005
Treatment of Primary CNS Lymphoma with Methotrexate and Deferred Radiotherapy: A Report of NABTT 96-07
J Clin Oncol 21:1044-1049, Batchelor,T.,et al, 2003
German Cancer Society Neuro-Oncology Working Group NOA-03 Multicenter Trial of Single-Agent High-Dose Methotrexate for Primary Central Nervous System Lymphoma
Ann Neurol 51:247-252, Herrlinger,U.,et al, 2002
An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002
Hypertrophic Chronic Pachymeningitis as a Localized Immune Process in the Craniocervical Region
Neurol 56:107-109, Boller,B.,et al, 2001
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Therapy of Primary CNS Lymphoma with Methotrexate-Based Chemotherapy and Deferred Radiotherapy:Prelimary Results
Neurol 46:1757-1759, Cher,L.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995
Stroke-Like Syndrome, Mineralizing Microangiopathy, and Neuroaxonal Dyst with Intrathecal Methotrexate
Neurol 41:1847-1848, Phanthumchinda,K.,et al, 1991
Central Nervous System Metastases from Non-Hodgkin's Lymphoma:Treatment & Prophylaxis
Am J Med 84:425-435, Recht,L.,et al, 1988
Cerebral Reticulum Cell Sarcoma
Arch Neurol 36:727, DeCoul,A.A.W.,et al, 1979
Central Nervous System Lesions in Childhood Leukemia
Neurol 28:678, Crosley,C.J.,et al, 1978
Methotrexate Dist. in CSF after IV, Ventricular & Lumbar Inject
NEJM 293:161, Shapiro,W.R.,et al, 1975